Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David V Sheehan

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Human Psychopharmacology|June 18, 2011
Clinical and functional outcomes in patients with major depressive disorder and painful physical symptoms switched to treatment with duloxetineDavid V Sheehan, Pratap R Chokka, Renee E Granger, et al.
Eating and Weight Disorders : EWD|March 5, 2016
A systematic review of the health-related quality of life and economic burdens of anorexia nervosa, bulimia nervosa, and binge eating disorderTamás Ágh, Gábor Kovács, Dylan Supina, et al.
CNS Drugs|October 9, 2008
Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disordersDavid V Sheehan, Matthew S Keene, Michael Eaddy, et al.
Human Psychopharmacology|September 3, 2015
Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitorsDavid V Sheehan, Michele Mancini, Jianing Wang, et al.
Journal of Affective Disorders|June 21, 2016
Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environmentRichard H Weisler, Ai Ota, Kana Tsuneyoshi, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 23, 2011
Antidepressant use in geriatric populations: the burden of side effects and interactions and their impact on adherence and costsTami L Mark, Vijay N Joish, Joel W Hay, et al.
The Journal of Clinical Psychiatry|January 7, 2011
Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trialMaurizio Fava, Gregory M Asnis, Ram K Shrivastava, et al.
Journal of Affective Disorders|August 28, 2012
Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patientDavid V Sheehan, Kathy Harnett-Sheehan, Rosario B Hidalgo, et al.
Innovations in Clinical Neuroscience|December 19, 2014
Simple Measures of Hopelessness and Impulsivity are Associated with Acute Suicidal Ideation and Attempts in Patients in Psychiatric CrisisCheryl B Mccullumsmith, David J Williamson, Roberta S May, et al.
Brain and Behavior|March 16, 2017
The effect of vortioxetine on overall patient functioning in patients with major depressive disorderIoana Florea, Henrik Loft, Natalya Danchenko, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Human Psychopharmacology|June 18, 2011
Clinical and functional outcomes in patients with major depressive disorder and painful physical symptoms switched to treatment with duloxetineDavid V Sheehan, Pratap R Chokka, Renee E Granger, et al.
Eating and Weight Disorders : EWD|March 5, 2016
A systematic review of the health-related quality of life and economic burdens of anorexia nervosa, bulimia nervosa, and binge eating disorderTamás Ágh, Gábor Kovács, Dylan Supina, et al.
CNS Drugs|October 9, 2008
Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disordersDavid V Sheehan, Matthew S Keene, Michael Eaddy, et al.
Human Psychopharmacology|September 3, 2015
Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitorsDavid V Sheehan, Michele Mancini, Jianing Wang, et al.
Journal of Affective Disorders|June 21, 2016
Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environmentRichard H Weisler, Ai Ota, Kana Tsuneyoshi, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 23, 2011
Antidepressant use in geriatric populations: the burden of side effects and interactions and their impact on adherence and costsTami L Mark, Vijay N Joish, Joel W Hay, et al.
The Journal of Clinical Psychiatry|January 7, 2011
Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trialMaurizio Fava, Gregory M Asnis, Ram K Shrivastava, et al.
Journal of Affective Disorders|August 28, 2012
Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patientDavid V Sheehan, Kathy Harnett-Sheehan, Rosario B Hidalgo, et al.
Innovations in Clinical Neuroscience|December 19, 2014
Simple Measures of Hopelessness and Impulsivity are Associated with Acute Suicidal Ideation and Attempts in Patients in Psychiatric CrisisCheryl B Mccullumsmith, David J Williamson, Roberta S May, et al.
Brain and Behavior|March 16, 2017
The effect of vortioxetine on overall patient functioning in patients with major depressive disorderIoana Florea, Henrik Loft, Natalya Danchenko, et al.
Pageof 9